Senate hearing into Valeant includes top hedge fund investor
Tuesday, April 26, 2016 - 11:31
in Mathematics & Economics
WASHINGTON (AP) -- Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the company's leading investors, hedge fund manager William Ackman....